跳转至内容
Merck
CN

A3449

Acrylamide/Bis-acrylamide solution

30%, BioReagent, suitable for electrophoresis, 19:1

别名:

30% Acrylamide/Bisacrylamide 19:1, Polyacrylamide solution

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41105319
PubChem Substance ID:
NACRES:
NA.25
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

丙烯酰胺/双丙烯酰胺,30% 溶液, BioReagent, suitable for electrophoresis, 19:1

sterility

0.2 μm filtered

Quality Level

product line

BioReagent

form

liquid

feed ratio

19:1

technique(s)

electrophoresis: suitable

suitability

suitable for electrophoresis

foreign activity

Protease, none detected

storage temp.

2-8°C

SMILES string

NC(=O)C=C.C=CC(=O)NCNC(=O)C=C

InChI

1S/C7H10N2O2.C3H5NO/c1-3-6(10)8-5-9-7(11)4-2;1-2-3(4)5/h3-4H,1-2,5H2,(H,8,10)(H,9,11);2H,1H2,(H2,4,5)

InChI key

OCQZXMCGTAWGEQ-UHFFFAOYSA-N

General description

聚丙烯酰胺凝胶是使用丙烯酰胺和双丙烯酰胺制备的,其中双丙烯酰胺是一种交联剂。另一方面,丙烯酰胺是水溶性单体,有助于形成透明稳定的不溶性凝胶。

Application

30% 的丙烯酰胺/双丙烯酰胺用于制备进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)所需的 5% 浓缩胶和 7% 分离胶。
这些30%(w/w)丙烯酰胺/双丙烯酰胺溶液能够以最常用的比例用于蛋白质和核酸电泳。浓度是基于丙烯酰胺和双丙烯酰胺的总重量进行计算的。

Preparation Note

由电泳级丙烯酰胺和双丙烯酰胺在超纯水中制备的溶液。


Still not finding the right product?


pictograms

Health hazardExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Carc. 1B - Eye Irrit. 2 - Muta. 1B - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1 Oral

target_organs

Peripheral nervous system

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容


The
Ana Techniqs in Biotechnology (2011)
Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55
Al-Sulaiman AM, et al.
Clinical and Vaccine Immunology : CVI, 16(6), 931-934 (2009)
Kei Ihira et al.
Oncotarget, 8(8), 13509-13520 (2017-01-16)
EZH2 inhibition and reactivation of tumor suppressor microRNAs (miRNAs) represent attractive anti-cancer therapeutic strategies. We found that EZH2-suppressed let 7b and miR-361, two likely tumor suppressors, inhibited endometrial cancer (EC) cell proliferation and invasion, and abrogated cancer stem cell-like properties.



全球贸易项目编号

货号GTIN
A3449-100ML04061833360934
A3449-5L04061837689376
A3449-5X100ML04061833360941